Treatment of female stress urinary incontinence – UROLON injection in Medicus Clinic
Stress urinary incontinence (SUI) is the involuntary leakage of urine that occurs when pressure increases in the abdominal cavity, e.g. when coughing, sneezing, laughing, exercising, running or lifting heavier objects. For many women, this means a reduction in activity, a decrease in wellbeing and self-confidence. One of the modern, minimally invasive methods of treating WNM is the administration of UROLON in the urethral area.
In Medicus Clinic, the procedure is performed by dr. Piotr Grabiec , specialist urologist, with experience in the diagnosis and treatment of urinary incontinence and endoscopic procedures.
What is UROLON?
UROLON is a bioresorbable implant administered by injection. It contains polycaprolactone (PCL) microspheres suspended in a gel carrier. The formulation is not a permanent implant and its component (PCL) has a proven safety profile.
Key features:
What is the mechanism of action?
During the procedure, UROLON is administered submucosally in the urethral region. The result is an increase in the volume of the tissues surrounding the coil. The tension of the structures is improved and the coil lumen is better 'sealed’. Urethral resistance increases, which translates into reduced episodes of urine leakage on exertion.
The gel carrier is gradually absorbed. The microspheres remain at the injection site and sustain the effect achieved.
The result is:
For whom is the treatment intended?
Treatment with UROLON can be offered to women with stress urinary incontinence. The method is also being considered for patients who are unwilling or unable to undergo surgical treatment. It is also sometimes chosen when previous treatment methods have failed to bring the expected improvement.
How does the procedure in Medicus Clinic proceed?
The procedure is performed in the office and usually does not take long. Prior to the procedure, a urological consultation is required and a urine test with culture is performed. The patient is prepared for the cystoscopic examination. The urologist usually applies a special anaesthetic and lubricating gel to the urethra, which reduces pain and facilitates insertion of the cystoscope. The next stages are:
Hospitalisation is not required.
Contraindications
The procedure is not performed in every situation. The procedure is usually not performed in female patients, among others:
The final qualification always takes place during the medical consultation.
Possible side effects
Temporary discomfort may occur after the procedure. A burning sensation on urination, more frequent visits to the toilet, slight hematuria or temporary difficulty emptying the bladder are described. These symptoms usually resolve spontaneously.
If they persist or worsen, contacting a doctor is advisable.
Recovery and recommendations after surgery
Most patients return to daily activities quickly, but mild urinary tract discomfort may persist for a short time. Individual recommendations (including possible activity restrictions) are given by the doctor after the procedure, depending on the patient’s condition and the course of the procedure. For female patients, it is advisable to consult a urogynaecoligical physiotherapy specialist after the procedure.